Phase I Dose-escalation Study Of The Bet Inhibitor Incb057643 In R/r Myelofibrosis

2024 1:52
Synopsis
Prithviraj Bose, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, comments on the safety results of a ...

You Might Also Like

Phase I/II study of a novel BET inhibitor, BMS-986158, alone & with ruxolitinib or fedratinib in MF 2:04
Phase I/ii Study Of A Novel Bet Inhibitor, Bms-986158, Alone...
2024
ABBV-744 and Mivebresib: BET inhibitors in myelofibrosis 2:18
Abbv-744 And Mivebresib: Bet Inhibitors In Myelofibrosis
2022
The first in-human Phase I study of a BET inhibitor for the treatment of NHL 4:24
The First In-human Phase I Study Of A Bet Inhibitor For The ...
2017
What is the rationale for using BET inhibitors to treat myelofibrosis? 1:59
What Is The Rationale For Using Bet Inhibitors To Treat Myel...
2023
An update of IMproveMF: dose-escalation of imetelstat + ruxolitinib in patients with myelofibrosis 2:46
An Update Of Improvemf: Dose-escalation Of Imetelstat + Ruxo...
2026
ZEN-3694, a novel BET inhibitor, in TNBC without germline BRCA1/2 mutations 3:39
Zen-3694, A Novel Bet Inhibitor, In Tnbc Without Germline Br...
2023
An update on BET inhibition for the treatment of myelofibrosis 2:34
An Update On Bet Inhibition For The Treatment Of Myelofibros...
2026
MANIFEST update: pelabresib clinical and pathological investigations 2:10
Manifest Update: Pelabresib Clinical And Pathological Invest...
2023
A Phase I study investigating ruxolitinib and abemaciclib for primary or secondary myelofibrosis 2:15
A Phase I Study Investigating Ruxolitinib And Abemaciclib Fo...
2023
David Lucas Discusses the Bromodomain Inhibitor OTX015 0:58
David Lucas Discusses The Bromodomain Inhibitor Otx015
2015
BET inhibition for the treatment of myelofibrosis 2:10
Bet Inhibition For The Treatment Of Myelofibrosis
2025
Download Options
Choose a download method below. All links open in new tabs.
Service Features Action
SaveFrom
MP4 & MP3 • HD Quality • Browser Extension Available
Download
Security Notice: These are third-party services. We recommend using antivirus software and being cautious of pop-up ads.